BetterLife Pharma Inc. (OTCMKTS:BETRF) Short Interest Update

BetterLife Pharma Inc. (OTCMKTS:BETRF) saw a significant growth in short interest in the month of November. As of November 30th, there was short interest totalling 13,800 shares, a growth of 89.0% from the November 15th total of 7,300 shares. Based on an average trading volume of 27,800 shares, the short-interest ratio is currently 0.5 days.

BetterLife Pharma Price Performance

BETRF opened at $0.07 on Friday. The company has a market cap of $9.39 million, a price-to-earnings ratio of -2.42 and a beta of 1.34. The firm’s fifty day simple moving average is $0.08 and its two-hundred day simple moving average is $0.09. BetterLife Pharma has a 52-week low of $0.03 and a 52-week high of $0.15.

BetterLife Pharma (OTCMKTS:BETRF) last posted its quarterly earnings data on Wednesday, September 25th. The company reported ($0.01) earnings per share (EPS) for the quarter.

BetterLife Pharma Company Profile

BetterLife Pharma Inc, a biotechnology company, engages in the development and commercialization of compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections.